Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib

doi:10.3748/wjg.v24.i4.484

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7402)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

449

WORD

367

HTML

3985

Figures (1-2)

158

Tables (1-5)

154

Sum=5113

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

967

Download

1322

Sum=2289

Jan 28, 2018 (publication date) through May 6, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jan 28, 2018; 24(4): 484-493
Published online Jan 28, 2018. doi: 10.3748/wjg.v24.i4.484

Table 3 Multivariate Cox proportional hazards regression analysis for overall survival

Factor	HR (95%CI)	P value
Previous TACE
No	1
Yes	2.552 (1.477-4.412)	0.001
PVTT
Absent	1
Present	2.582 (1.608-4.146)	< 0.001
Early disease control
No	1
Yes	0.564 (0.339-0.936)	0.027
Extrahepatic metastasis
No	1
Yes	1.193 (0.680-2.092)	0. 538

HR: Hazard ratio; CI: Confidence interval; PVTT: Portal vein tumor thrombus; TACE: Transarterial chemoembolization.

Citation: Meng XC, Chen BH, Huang JJ, Huang WS, Cai MY, Zhou JW, Guo YJ, Zhu KS. Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib. World J Gastroenterol 2018; 24(4): 484-493
URL: https://www.wjgnet.com/1007-9327/full/v24/i4/484.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i4.484